Medication info
Ducravog 30/5/10 mg (Pimasartan Potassium, Amlodipine, Rosuvastatin)

Ducravog 30/5/10 mg (Pimasartan Potassium, Amlodipine, Rosuvastatin)

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate Granules›75mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tabletRosuvastatin Calcium Micronized›10.4mg / 1 tablet
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
Pale green pentagonal film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP*3]
Approval status
Active

MFDS item code 201907897 · Approved 2019.11.13 · Insurance code 641907380

Summary

Main use
Treatment of hypertension, improvement of dyslipidemia, and inhibition of atherosclerosis progression and cardiovascular risk
Who takes it
Adults · Children
Adult dose
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the fimasartan/amlodipine combination and rosuvastatin. Patients taking the fimasartan/amlodipine combination together with rosuvastatin as a single-ingredient product may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Fimasartan/Amlodipine Combination Adults Before starting the fimasartan/amlodipine combination, it is recommended that the dose be adjusted using fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 30/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy or 30/5 mg. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or 60/5 mg. Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a lower dose, and the dose should be increased gradually. Patients with renal impairment No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. This medicine should not be administered to patients with moderate ~ severe hepatic impairment. Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients receiving rosuvastatin should follow a standard cholesterol-lowering diet before and during treatment and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, regardless of meals. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which provides adequate control in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of rosuvastatin 40 mg is contraindicated in some of these patients.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension, improvement of dyslipidemia, and inhibition of atherosclerosis progression and cardiovascular risk

  • Essential hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • combined dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • primary dysbetalipoproteinemia
  • risk factors for coronary artery disease
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of early coronary artery disease
View approved original text

This medication is used as a combination of Pimasartan and Amlodipine for patients with essential hypertension whose blood pressure is not adequately controlled, and for patients who need to manage hypercholesterolemia and dyslipidemia with Rosuvastatin. Rosuvastatin helps manage hypercholesterolemia and dyslipidemia that are not controlled by diet and exercise, and is particularly effective at slowing the progression of atherosclerosis and reducing cardiovascular disease risk. Additionally, it contributes to reducing the risk of myocardial infarction, stroke, and recurrence after angioplasty. Therefore, this medication is used to simultaneously manage hypertension and hyperlipidemia for improved cardiovascular health.

How to take

Adult dose

Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the fimasartan/amlodipine combination and rosuvastatin. Patients taking the fimasartan/amlodipine combination together with rosuvastatin as a single-ingredient product may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Fimasartan/Amlodipine Combination Adults Before starting the fimasartan/amlodipine combination, it is recommended that the dose be adjusted using fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 30/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy or 30/5 mg. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or 60/5 mg. Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a lower dose, and the dose should be increased gradually. Patients with renal impairment No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. This medicine should not be administered to patients with moderate ~ severe hepatic impairment. Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients receiving rosuvastatin should follow a standard cholesterol-lowering diet before and during treatment and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, regardless of meals. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which provides adequate control in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of rosuvastatin 40 mg is contraindicated in some of these patients.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be taken by individuals allergic to any ingredients in this medication or by those with specific liver diseases, kidney diseases, or muscle disorders. Patients with very low blood pressure or low blood volume, those with impaired kidney function, and elderly individuals should exercise caution when taking this medication and should have their conditions monitored frequently. If symptoms of muscle pain or weakness occur, consult a doctor immediately, and in severe cases, discontinue the medication. This medication can affect the liver and kidneys, so regular liver and kidney function tests should be conducted before and during treatment. There may be interactions with other medications, so if you are currently taking any other medications, you must inform your healthcare provider. Pregnant women or those planning to become pregnant should consult a doctor and use appropriate contraception. If breastfeeding, this medication can be transmitted through breast milk, so it is important to either discontinue breastfeeding or decide on use after consulting with a doctor. Overdose may lead to hypotension, cardiac arrhythmias, and require immediate medical attention. Dizziness may occur while driving or operating machinery, so caution is advised. Keep out of reach of children and do not transfer to other containers.

Side effects

  • Nausea
  • peripheral edema
  • nasopharyngitis
  • influenza
  • increased serum creatine phosphokinase
  • dizziness
  • essential tremor
  • rash
  • pruritus
  • headache
Show 384 more
  • fainting
  • sedation
  • migraine
  • dyspepsia
  • vomiting
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • facial flushing
  • erectile dysfunction
  • facial edema
  • urinary dysfunction
  • insomnia
  • flushing
  • proteinuria
  • dizziness
  • orthostatic dizziness
  • headache
  • facial edema
  • peripheral edema
  • urinary dysfunction
  • insomnia
  • flushing
  • headache
  • dizziness
  • fainting
  • sedation
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • pruritus
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • fatigue
  • edema
  • palpitations
  • dizziness
  • drowsiness
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • tension increase
  • sensory impairment
  • sensory abnormalities
  • peripheral neuropathy
  • taste disturbance
  • tremors
  • extrapyramidal disorder
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • cough
  • dyspnea
  • alopecia
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary dysfunction
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzyme levels
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • cutaneous erythema
  • papular urticaria
  • heaviness
  • heat sensation
  • impaired glucose tolerance
  • weakness
  • angioedema
  • hypersensitivity reactions
  • diabetes
  • headache
  • dizziness
  • constipation
  • nausea
  • abdominal pain
  • pancreatitis
  • pruritus
  • rash
  • urticaria
  • myalgia
  • myopathy
  • rhabdomyolysis
  • weakness
  • polyneuropathy
  • amnesia
  • peripheral neuropathy
  • ulcerative stomatitis
  • peptic ulcer
  • toothache
  • gas bloating
  • oral bleeding
  • hemorrhoids
  • dryness
  • acute pancreatitis
  • colitis
  • colon polyp
  • gum pain
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • periodontitis
  • saliva secretion
  • melena
  • gastroesophageal reflux
  • constipation
  • gastritis
  • rash
  • onychomycosis
  • seborrheic dermatitis
  • skin disease
  • keratosis
  • sweating
  • onychodystrophy
  • paronychia
  • contact dermatitis
  • alopecia
  • dermatitis
  • osteoarthritis
  • muscle weakness
  • tendinitis
  • osteomyelitis
  • shoulder impingement syndrome
  • lateral epicondylitis
  • synovitis
  • sciatica
  • jaw pain
  • arthralgia
  • arthrosis
  • osteoporosis
  • muscle weakness
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • cerebral hemorrhage
  • arteriosclerosis
  • peripheral vascular disease
  • varicose veins
  • carpal tunnel syndrome
  • pulmonary tuberculosis
  • axillary pain
  • periorbital edema
  • allergy
  • chills
  • worsening low back pain
  • nasal polyp
  • edema
  • peripheral edema
  • pneumonia
  • lung disease
  • hemoptysis
  • worsening rhinitis
  • fibrosing alveolitis
  • asthma
  • pulmonary granuloma
  • abnormal chest X-ray
  • pharyngitis
  • sputum
  • bronchitis
  • hypercholesterolemia
  • diabetes
  • hypertriglyceridemia
  • thirst
  • worsening diabetes
  • calcification
  • hyponatremia
  • gout
  • eye pain
  • retinal disease
  • glaucoma
  • cataract
  • diplopia
  • floaters
  • uveitis
  • visual abnormalities
  • retinal disease
  • floaters
  • worsening chronic kidney failure
  • cystitis
  • urinary tract infection
  • increased BUN
  • acute kidney failure
  • pyelonephritis
  • frequency
  • worsening chronic kidney failure
  • otitis media
  • fungal infection
  • abscess
  • bacterial infection
  • genital herpes
  • cold sores
  • shingles
  • colon carcinoma
  • neoplasm of unspecified nature
  • liver cancer
  • cervical cancer
  • prostate cancer
  • thrombocytosis
  • panic reaction
  • Alzheimer's disease
  • suicide attempt
  • anxiety
  • insomnia
  • depression
  • hyperthyroidism
  • hypothyroidism
  • elevated TSH
  • benign pituitary neoplasm
  • atrial fibrillation
  • bradycardia
  • arrhythmia
  • ventricular arrhythmia
  • tachycardia
  • coronary artery disease
  • arterial stenosis
  • aortic stenosis
  • angina
  • myeloproliferative disease
  • worsening anemia
  • iron deficiency anemia
  • tinnitus
  • hearing impairment
  • hearing loss
  • pelvic inflammatory disease
  • vaginitis
  • uterine prolapse
  • benign prostatic hyperplasia
  • scrotal pain
  • heart failure
  • blood pressure fluctuations
  • acute hepatitis
  • alcoholic liver disease
  • localized inflammation
  • soft tissue inflammation
  • pulmonary embolism
  • lymphadenopathy
  • abrasion of unspecified nature
  • septal deviation
  • surgical intervention
  • postoperative pain
  • heat intolerance
  • recurrence of cancer
  • fall
  • chest pain
  • low back pain
  • edema
  • limb pain
  • fatigue
  • fever
  • neck/shoulder pain
  • fracture
  • arthralgia
  • insomnia
  • depression
  • anxiety
  • memory impairment
  • anorexia
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • functional gastrointestinal disorders
  • gastroenteritis
  • frequency
  • urinary incontinence
  • kidney stones
  • chronic kidney failure
  • difficulty urinating
  • hyperlipidemia
  • dyslipidemia
  • hypoglycemia
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neurocellulitis
  • blepharospasm
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • restless legs syndrome
  • ischemic neuropathy
  • sensory abnormalities
  • tremors
  • spinal canal stenosis
  • excessive muscle tone
  • panic reaction
  • Alzheimer's disease
  • suicide attempt
  • anxiety
  • insomnia
  • depression
  • hyperthyroidism
  • hypothyroidism
  • elevated TSH
  • benign pituitary neoplasm
  • atrial fibrillation
  • bradycardia
  • arrhythmia
  • ventricular arrhythmia
  • tachycardia
  • coronary artery disease
  • arterial stenosis
  • aortic stenosis
  • angina
  • myeloproliferative disease
  • worsening anemia
  • iron deficiency anemia
  • tinnitus
  • hearing impairment
  • hearing loss
  • pelvic inflammatory disease
  • vaginitis
  • uterine prolapse
  • benign prostatic hyperplasia
  • scrotal pain
  • heart failure
  • blood pressure fluctuations
  • acute hepatitis
  • alcoholic liver disease
  • localized inflammation
  • soft tissue inflammation
  • pulmonary embolism
  • lymphadenopathy
  • abrasion of unspecified nature
  • septal deviation
  • surgical intervention
  • postoperative pain
  • heat intolerance
  • recurrence of cancer
  • fall

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and should be kept at a temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's efficacy and prevent degradation.

Appearance and packaging

Appearance

Pale green pentagonal film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP*3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.